collection of sample and data
OtherRecovery of surgical waste during surgery planned in the current care and clinical data collection
NCT Number: NCT03622983
The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.
Interested in participating?
Request Info18 year and older
Female
Observational
CHI Creteil, Créteil, France
The management of pelvic gynecological cancers (PGC) is based on the determination of the extension in order to guide the treatments. The biology of PGC is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing of ovarian tumors allows selection of patients who may benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify factors that predict recurrence of these cancers. The results have obtained are very promising, but if coordinator team have at our disposal fundamental and translational data related to the prognosis of PGCs, the coordinator team lack access to a biological collection of these cancers that would allow us to test our hypotheses and to develop personalized medicine related to the clinico-biological characteristics of the patients.
Endometriosis is the 1st cause of chronic pelvic pain (25-40% of women suffering during sexual intercourse) and represents the 1st cause of school and work absenteeism. Unfortunately, it is under-diagnosed and too often inappropriately managed. It is considered that 10 to 15% of the female population of reproductive age has endometriosis. This incidence reaches 50% in women with infertility. There are many similarities between deep endometriosis and pelvic cancers, whether on a physiopathological, epidemiological or clinical level. There are therefore many similarities in the surgical management as well as in the research strategies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Recovery of surgical waste during surgery planned in the current care and clinical data collection
Time frame: 2 years
Time frame: 2 years
Time frame: 5 years
Time frame: 10 years
Time frame: 2 years
Time frame: 5 years
Time frame: 10 years
Time frame: 2 years
Time frame: 5 years
Time frame: 10 years
Time frame: day of surgery
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Intercommunal Creteil
Other
Acronym: PELVIMASS2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06820320
Abdominal Neoplasm, Abdominal Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT01103492
Digestive System Diseases, Endometrial Neoplasms
Cleveland, Ohio, United States
View Trial DetailsNCT00186953
Abdominal Neoplasms, Neoplasms
Memphis, Tennessee, United States
View Trial DetailsNCT00191646
Abdominal Neoplasms, Adnexal Diseases
Phoenix, Arizona, United States
View Trial Details